Largest biotech companies by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Moderna has the lowest figure of the 24 biotech companies ranked by earnings, at -NOK 27.3B, followed by BioNTech (-NOK 12.2B) and Revolution Medicines (-NOK 11B). Figures as of 18 Nov 2026, 18:19 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- Lowest
- Moderna-NOK 27.3B
- Median
- -NOK 664.7M
- Combined market value
- NOK 8.15T
- Countries
- 5
Market values as of .
All countries▾
All sectors▾
Biotech▾
| # | Company | Earnings ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ModernaMRNA · Health Care | -NOK 27.3B | NOK 788.2B | NOK 1,948.02 | 2.80% down | 755% up | ||
| 2 | BioNTechBNTX · Health Care | -NOK 12.2B | NOK 201.7B | NOK 813.52 | 1.08% down | 16% down | ||
| 3 | Revolution MedicinesRVMD · Health Care | -NOK 11B | NOK 334.6B | NOK 1,547.18 | 1.87% down | 131% up | ||
| 4 | VaxcytePCVX · Health Care | -NOK 7.4B | NOK 89.9B | NOK 567.93 | 1.35% down | 22% up | ||
| 5 | CRISPR TherapeuticsCRSP · Health Care | -NOK 5.6B | NOK 39B | NOK 401.72 | 3.24% up | 21% down | ||
| 6 | ImmunovantIMVT · Health Care | -NOK 4.9B | NOK 67.1B | NOK 324.19 | 0.72% up | 43% up | ||
| 7 | Scholar Rock HoldingSRRK · Health Care | -NOK 3.7B | NOK 56.1B | NOK 460.16 | 5.32% up | 14% up | ||
| 8 | ImmunityBioIBRX · Health Care | -NOK 3.4B | NOK 68.9B | NOK 64.74 | 6.71% up | 193% up | ||
| 9 | Kymera TherapeuticsKYMR · Health Care | -NOK 3B | NOK 101.2B | NOK 1,185.67 | 0.67% up | 87% up | ||
| 10 | Kodiak SciencesKOD · Health Care | -NOK 2.2B | NOK 61.4B | NOK 938.44 | 0.03% up | 396% up | ||
| 11 | CG OncologyCGON · Health Care | -NOK 1.6B | NOK 70.4B | NOK 788.32 | 3.04% up | 85% up | ||
| 12 | Twist BioscienceTWST · Health Care | -NOK 752.8M | NOK 77.5B | NOK 1,136.35 | 4.69% up | 340% up | ||
| 13 | Adaptive BiotechnologiesADPT · Health Care | -NOK 576.6M | NOK 45.1B | NOK 278.68 | 0.93% up | 88% up | ||
| 14 | RepligenRGEN · Health Care | NOK 473.9M | NOK 107.7B | NOK 1,684.41 | 7.16% up | 5% up | ||
| 15 | Bio-TechneTECH · Health Care | NOK 1.8B | NOK 110.8B | NOK 705.60 | 0.24% up | 26% up | ||
| 16 | Krystal BiotechKRYS · Health Care | NOK 2B | NOK 89.7B | NOK 3,028.64 | 4.67% up | 46% up | ||
| 17 | Halozyme TherapeuticsHALO · Health Care | NOK 3.1B | NOK 106.8B | NOK 937.09 | 0.75% up | 37% up | ||
| 18 | QiagenQGEN · Health Care | NOK 4.1B | NOK 99.4B | NOK 481.58 | 0.12% down | 12% up | ||
| 19 | Neurocrine BiosciencesNBIX · Health Care | NOK 4.6B | NOK 160.4B | NOK 1,584.58 | 1.46% down | 20% up | ||
| 20 | ExelixisEXEL · Health Care | NOK 7.6B | NOK 163.5B | NOK 670.08 | 0.93% up | 63% up | ||
| 21 | argenxARGX · Health Care | NOK 12.5B | NOK 576.9B | NOK 9,174.36 | 0.09% down | 4% up | ||
| 22 | BiogenBIIB · Health Care | NOK 12.5B | NOK 361.3B | NOK 2,444.23 | 0.56% up | 49% up | ||
| 23 | AmgenAMGN · Health Care | NOK 74.7B | NOK 2.34T | NOK 4,327.22 | 2.50% down | 34% up | ||
| 24 | Gilead SciencesGILD · Health Care | NOK 82.5B | NOK 2.04T | NOK 1,641.47 | 0.52% down | 33% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 9.6916 NOK).
Questions and answers
Which biotech companies have the lowest earnings?
Moderna (-NOK 27.3B), BioNTech (-NOK 12.2B) and Revolution Medicines (-NOK 11B) have the lowest earnings of the 24 biotech companies ranked here as of 18 Nov 2026, 18:19 UTC.
How many biotech companies are in this ranking?
24 are ranked by earnings.
What are these biotech companies worth together?
The 24 biotech companies ranked by earnings have a combined market value of NOK 8.15T as of 18 Nov 2026, 18:19 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest biotech companies by earnings”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.